Search results - Portal of Medical Data Models (MDM-Portal)

Filter search results
Select data models

Selected data models

You must log in to select data models for download or further analysis.

1 Search results.

7% CO2, GW597599, paroxetine andor alprazolam in healthy volunteers 100690 - Screening Laboratory Collections

- 10/18/17 - 1 form, 7 itemgroups, 20 items, 1 language

Itemgroups: Administrative Documentation, Estradiol | FSH, Clinical Chemistry and Haematology, Urinanalysis, Drug Screening (Urine), HIV and Hepatitis B & C, Pregnancy Test

Study ID: 100690 Clinical Study ID: NKP100690 Study Title: A randomised, double blind triple dummy, placebo controlled balanced incomplete block crossover study to evaluate the change in response to a 7% CO2 challenge and pharmacokinetics of single oral doses of GW597599 and paroxetine (5 or 7.5 mg) either alone or in combination, or alprazolam (0.75 mg) in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: paroxetine Trade Name: Tagonis,Seroxat,Paxil,Paroxat,Deroxat,Aropax Study Indication: Depressive Disorder and Anxiety Disorders CRF Seiten: 255-365

Keywords

Table of contents

Selected data models

7% CO2, GW597599, paroxetine andor alprazolam in healthy volunteers 100690 - Screening Laboratory Collections

Keywords

Table of contents

Selected data models

7% CO2, GW597599, paroxetine andor alprazolam in healthy volunteers 100690 - Screening Laboratory Collections

Contact

Help